Today: 27 June 2026
Browse Category

NASDAQ:AAPL 23 June 2026 - 27 June 2026

AI stocks eye $41 billion tech-fund shift as memory costs hit

AI stocks eye $41 billion tech-fund shift as memory costs hit

Technology sector funds saw nearly $20 billion in outflows the week to June 24—erasing the prior week’s $21.46 billion inflows—just before chip stocks plunged, with the Nasdaq dropping 4.6% and the Philadelphia semiconductor index posting its worst week since April, as investors questioned AI profitability and shifted away from tech.
US futures edge lower ahead of Russell index reshuffle as chip stocks see selling

US stocks: After-hours chips slump overshadows gains ahead of jobs data

PHLX chip index plunged 5.3% Friday and 7.9% for the week as surging memory costs hit device makers like Apple, driving $20 billion in tech fund outflows and raising inflation fears, while S&P 500 advancers outnumbered decliners and after-hours trading showed no clear tech rebound.
Tech fund outflows hit US stocks after hours as AI trade momentum cools

Tech fund outflows hit US stocks after hours as AI trade momentum cools

Tech sector funds saw nearly $20 billion in weekly outflows, reversing last week’s record inflow, as the Nasdaq 100 slid 1.09% and chip stocks tumbled, with the PHLX semiconductor index down over 4% for its biggest weekly drop since March, raising fresh concerns for investors in large tech and chip names.
Dow trades stable close to 52,000; Alphabet change stirs talk on price weighting

Dow trades stable close to 52,000; Alphabet change stirs talk on price weighting

Alphabet (NASDAQ:GOOGL) will replace Verizon in the Dow before Monday’s open, boosting the index’s exposure to high-priced tech stocks after S&P Dow Jones Indices said Verizon’s low share price gave it minimal weight; no mechanical index jump is expected at the open.
US stocks mixed, Micron AI memory rally can’t lift Nasdaq

US stocks: Wall Street splits as chips drop but megacap platforms hold indexes

iShares Semiconductor ETF (SOXX) plunged 4.67% while S&P 500 was nearly flat, as chipmakers like Nvidia, Micron, and AMD fell sharply amid concerns over memory supply costs and inflation, with Micron dropping 4.17% after a previous surge and ON Semiconductor tumbling 20.97% on a $7 billion Synaptics acquisition.
US futures edge lower ahead of Russell index reshuffle as chip stocks see selling

US futures edge lower ahead of Russell index reshuffle as chip stocks see selling

Russell index reconstitution triggers nearly $150 billion in expected forced trades after Friday’s close, with 62 companies joining the Russell 1000 and 237 joining the Russell 2000, potentially driving major end-of-day volatility as funds reset benchmark exposure, Reuters reports.
US stocks mixed, Micron AI memory rally can’t lift Nasdaq

US stocks mixed, Micron AI memory rally can’t lift Nasdaq

Micron soared 15.7% after announcing $22 billion in customer commitments for memory chips, signaling persistent supply tightness and pricing power for chipmakers, while device makers like Apple fell 6.1% on margin pressure from rising component costs, highlighting a split in the AI trade that could reshape stock performance across the tech sector.
Micron, Qualcomm move up while Apple, Nvidia slide in mixed AI trade

Micron, Qualcomm move up while Apple, Nvidia slide in mixed AI trade

Micron surged on $22 billion in customer commitments as memory suppliers gained $239 billion in market value, while five AI-linked megacaps lost $417 billion, shifting investor focus from AI demand to pricing power amid tight memory supply and rising component costs.
Dow ends higher; Nasdaq drifts as AI stocks slip, oil falls

Dow Jones (INDEXDJX:.DJI) spikes 700 points as price-weighted stocks outpace tech slide

Dow soars 763.79 points as Caterpillar, Goldman Sachs, and Honeywell drive gains, offsetting Apple’s 4.8% drop; investors brace for Alphabet to replace Verizon in the Dow on June 29, a move set to shift index weightings for funds tracking the price-weighted average.
US stocks now: Broad gains balance $416 billion drop in megacap tech

US stocks now: Broad gains balance $416 billion drop in megacap tech

Apple, Nvidia, Microsoft, Alphabet, and Meta lost about $416 billion in combined market value as investors rotated into Dow and small-cap stocks, with Apple dragging after raising MacBook and iPad prices due to higher memory costs; meanwhile, Micron surged 10.4% on strong earnings and guidance, and Qualcomm gained 3.6% after boosting long-term revenue targets.
Apple (NASDAQ:AAPL) lifts MacBook and iPad prices, faces memory cost jump

Apple (NASDAQ:AAPL) lifts MacBook and iPad prices, faces memory cost jump

Apple (AAPL) shares plunged 4.8% to $278.93 after the company hiked Mac and iPad prices by $100–$300 due to soaring memory costs, while iPhone prices—over half of March-quarter sales—remained unchanged; Apple warned of further gross margin pressure from rising memory prices, as DRAM costs surged up to 98% last quarter and are set to climb again.
25 June 2026
Nasdaq Futures Drop Ahead of Open as Debt Concerns Hit AI Stocks

Nasdaq 100 Slides, Tech Stocks Wipe Out $1 Trillion

Nasdaq 100 futures plunged nearly 3% premarket as selling in AI-linked tech stocks intensified, putting over $1 trillion in market value at risk Tuesday; SpaceX dropped below a $2 trillion valuation and lost $600 billion in three sessions, while South Korea’s KOSPI tumbled 9.99% after Samsung and SK Hynix fell over 12% each, as investors question AI returns and brace for higher U.S. rates.
1 2 3 50

Stock Market Today

  • Nvidia Invests in AI-Driven Biotechnology Firm Generate Biomedicines, Targeting $1.8 Trillion Pharma Market
    June 27, 2026, 9:17 AM EDT. Nvidia (NASDAQ: NVDA) has acquired 833,325 shares in Generate Biomedicines (NASDAQ: GENB), a $2 billion market cap biotechnology company using AI to digitally test drug molecules. This minority stake reflects Nvidia's confidence in GENB's AI platform, which accelerates drug discovery by simulating molecule performance before costly clinical trials. Generate's pipeline includes four drug candidates, with one in phase 3 testing for severe asthma. Nvidia's venture capital arm NVentures' $13 million investment aligns with the tech giant's expertise in AI hardware, highlighting the growing convergence of AI and biopharma. The move positions Generate Biomedicines to potentially disrupt the $1.8 trillion pharmaceutical market by reducing drug development time and costs, addressing key industry challenges.

Latest articles

Oil Prices Today: Brent Whipsaws as Iran Peace Hopes Hit OPEC Supply Shock

Funds trim WTI longs, Hormuz supply flows ease squeeze from tight U.S. stocks

27 June 2026
Brent crude plunged 10.86% this week to $71.99 as funds slashed net long WTI positions by 13,356 contracts, despite Cushing inventories hitting their lowest since 2014 and U.S. diesel margins surging; investors face key risks from Hormuz traffic, U.S.-Iran tensions, OPEC+ output hikes, and China’s fuel export boost.
AI stocks eye $41 billion tech-fund shift as memory costs hit

AI stocks eye $41 billion tech-fund shift as memory costs hit

27 June 2026
Technology sector funds saw nearly $20 billion in outflows the week to June 24—erasing the prior week’s $21.46 billion inflows—just before chip stocks plunged, with the Nasdaq dropping 4.6% and the Philadelphia semiconductor index posting its worst week since April, as investors questioned AI profitability and shifted away from tech.
IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

IPO calendar eyes Bending Spoons as shortened week thins deal pipeline

27 June 2026
Bending Spoons (NASDAQ:BSP) drives 61% of next week’s $2.56 billion U.S. IPO proceeds, making its $1.57 billion raise a key test for investor appetite in debt-heavy software M&A, with a $18.1 billion valuation and 4.0x net debt to EBITDA leverage, as markets brace for a holiday-shortened week and a looming $29.4 billion SK hynix Nasdaq ADR.
Go toTop